Tartu - After disagreements over the prestigous Estonian Genome Project's (EGP) research focus, the EGP Foundation and the California-based investor EGeen International Corp. have signed an agreement in early April. Under its terms US-sponsor EGeen will finance the Genome Project with another a1.6 million (see EuroBiotechNews 3/04). However these funds will last only until November this year and ensure the collection of data of about 5,000 gene donors - the original plan had allotted 17,000 for 2004. Approximately another a8-10 million would be needed in order to continue the project until the end of the next financing round in 2006. By then the project had envisaged the collection of 100,000 blood samples. “Nego-tiations about financing the project for year 2005 are in progress. It is too early to foretell the results at the moment”, explained Aire Koik, head of information at the Estonian Genome Project Foundation, to EuroBiotechNews.